Can pulmonary hypertension exacerbate and lead to severe complications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Pulmonary Hypertension Exacerbate?

Yes, pulmonary hypertension is a progressive disease that exacerbates over time and can lead to life-threatening complications, particularly through right ventricular failure, acute decompensation, and sudden cardiac death. 1, 2

Progressive Nature and Mechanisms of Exacerbation

Pulmonary hypertension is characterized by adverse vascular remodeling with obstruction, stiffening, and vasoconstriction of the pulmonary vasculature that worsens without proactive management. 2 This progressive pulmonary vasculopathy leads to:

  • Right ventricular hypertrophy and ultimate failure, which is the main cause of death 2
  • Increased pulmonary vascular resistance that rises inexorably despite treatment 3
  • Pulmonary artery dilatation as the disease advances, even with PAH-specific drug therapy 4

High-Risk Exacerbation Scenarios

Pregnancy-Related Exacerbation

Severe pulmonary vascular disease carries the highest maternal mortality risk (30-50%) due to life-threatening further rises in pulmonary vascular resistance. 1 This occurs through:

  • Pulmonary thrombosis or fibrinoid necrosis developing particularly rapidly in the peripartum and postpartum periods, determining fatal outcomes even in previously minimally disabled patients 1
  • Increased right-to-left shunting in Eisenmenger syndrome due to systemic vasodilation and right ventricular overload, causing increased cyanosis and decreased pulmonary blood flow 1

Perioperative Exacerbation

Patients with severe pulmonary hypertension undergoing noncardiac surgery face significant risk of acute decompensation. 1 Emergency procedures carry 15% mortality compared to 2% in nonemergency surgeries. 1

  • Severe PH is defined hemodynamically as mean pulmonary artery pressure >40 mmHg, pulmonary vascular resistance >5 Wood units, or echocardiographic evidence of significant RV dysfunction 1
  • Invasive hemodynamic monitoring is reasonable during elevated-risk surgery to guide intraoperative and postoperative care 1

Life-Threatening Complications

Sudden Cardiac Death

Progressive pulmonary vasculopathy contributes to severe complications leading to sudden cardiac death, encountered more frequently in PAH patients. 4 These include:

  • Left main coronary artery compression syndrome 4
  • Pulmonary artery dissection 4
  • Pulmonary artery rupture 4
  • Severe hemoptysis 4

Cardiovascular Reserve Depletion

Any patient reaching WHO functional class III or IV represents high risk regardless of underlying condition, indicating no remaining cardiovascular reserve. 1 The hemodynamic changes during physiologic stress (pregnancy, surgery, exercise) exacerbate problems associated with the underlying disease. 1

Prognostic Indicators of Exacerbation

The following parameters predict disease progression and poor outcomes:

  • Advanced functional class (WHO III-IV) 1, 3
  • Poor exercise capacity measured by 6-minute walk test or cardiopulmonary exercise testing 1
  • High right atrial pressure 1, 3
  • Significant right ventricular dysfunction 1, 3
  • Low cardiac index 1, 3
  • Elevated brain natriuretic peptide 1
  • Pericardial effusion 3
  • Underlying scleroderma spectrum disease 1

Clinical Course Without Treatment

Pulmonary hypertension remains a serious disease with progressive and inexorable evolution despite treatment advances. 3 The prognosis is highly variable depending on:

  • Etiology of pulmonary hypertension 3
  • Functional class at presentation 3
  • Clinical, echocardiographic, and hemodynamic parameters 3

Approximately 15% mortality occurs within 1 year even on modern therapy. 1

Prevention of Exacerbation

Continuation of PAH-Specific Therapies

Continuation of PAH-targeted medical therapies (nitric oxide pathway inhibitors, endothelin receptor antagonists, prostacyclin pathway agonists) during perioperative periods is associated with lower morbidity and mortality. 1 Well-controlled PAH shows better outcomes during physiologic stress. 1

Regular Monitoring

Follow-up assessments every 3-6 months in stable patients are recommended to detect early signs of exacerbation. 1, 5

Avoidance of High-Risk Situations

  • Pregnancy must be avoided in PAH patients due to substantial mortality risk 1
  • Excessive physical activity leading to distressing symptoms should be avoided 1
  • General anesthesia should be avoided when epidural anesthesia is feasible for elective surgery 1

Common Pitfalls

Do not assume asymptomatic or mildly symptomatic patients are stable—even patients with little or no disability can experience rapid, life-threatening exacerbations, particularly during pregnancy or perioperative periods. 1

Do not delay referral to specialized pulmonary hypertension centers for high-risk patients, as multidisciplinary emergency care contributes to improved outcomes. 4

Do not discontinue PAH-specific medications during periods of physiologic stress without expert consultation, as this increases risk of acute decompensation. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pulmonary hypertension.

Nature reviews. Disease primers, 2024

Guideline

Management of Pulmonary Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.